Question 60

All blood glucose monitors in use will require new quality control measurement daily.

In the context of merging a new and an old medical office, it is essential that all blood glucose monitors currently in use undergo new quality control measurements daily to ensure accuracy and reliability across the combined facilities.

A) All blood glucose monitors in use

This option is correct because merging two offices necessitates that every blood glucose monitor, regardless of its origin, be assessed for quality control. Different monitors may have varying calibration and performance standards, so daily measurements are essential to maintain consistent and reliable patient care.

B) Blood glucose monitors in use from the new office only

This option is incorrect because it suggests that only the monitors from the new office would be subject to new quality control measures. Given that the monitors from the old office are also in use, neglecting them could lead to inaccuracies in patient testing and care.

C) Blood glucose monitors in use from the old medical office only

This option is also incorrect as it implies that only the old office's monitors would be monitored for quality control. This could compromise patient safety, as devices from both offices need to be evaluated to ensure they meet current standards.

D) None of the blood glucose monitors

This option is incorrect because it suggests that no monitors would undergo quality control measurement, which would be irresponsible and unsafe. All devices must be regularly checked to guarantee their efficacy and reliability in patient care.

Conclusion

The requirement for all blood glucose monitors in use to undergo new quality control measurements daily is critical to ensure the accuracy and safety of patient testing in the merged medical office. All other options fail to recognize the importance of maintaining high standards across both facilities. Therefore, option A is the only suitable choice for ensuring optimal patient care.